Evidence map›Paper›PMID 42252444›Full record

ArticleVirology journal2026

Single-cell characterization of the CD8

Jun Lei, Jialingfang, Aifang Xu

Abstract read
In one paragraph

Article in Virology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jun Lei *Department of Laboratory Medicine, Hangzhou Xixi Hospital, Zhejiang Chinese Medical University, Hangzhou, China. leijun@whu.edu.cn.
Jialingfang *Liangzhu Laboratory, Zhejiang University, Hangzhou, Zhejiang, China.
Aifang XuDepartment of Laboratory Medicine, Hangzhou Xixi Hospital, Zhejiang Chinese Medical University, Hangzhou, China. xuaifangxxh@163.com.

Funding

National Natural Science Foundation of China 32301017
6 · The paper itself

Abstract

Although antiretroviral therapy (ART) effectively suppresses HIV-1 viremia, immune dysfunction often persists. Here, we integrated single-cell RNA and T cell receptor (TCR) sequencing data to delineate the alterations of CD8⁺ T cells. Based on cross-sectional samples from different individuals (healthy donors, treatment-naïve individuals, and ART-treated individuals), we found ART promoted the transition of CD8⁺ T cells from exhausted toward naïve and memory-like subsets. Weighted gene co-expression network analysis identified distinct modules, including three (SM2-SM4) highly expressed in treatment-naïve individuals and one (SM6) significantly elevated post-ART. The reduced TCR diversity and increased clonality observed post-infection were not fully restored by ART, although ART partly altered clonal structure and CDR3 length. We established a predictive model based on the TCR features of CD8⁺ T cells, which accurately distinguished healthy donors, treatment-naïve individuals, and ART-treated individuals. These findings clarify the complex landscape of CD8⁺ T cell reconstitution, and identify key transcriptional networks and clonal dynamics during ART.

Indexed as

Anti-Retroviral AgentsCD8-Positive T-LymphocytesHIV-1HIV InfectionsSingle-Cell AnalysisCross-Sectional StudiesHumansReceptors, Antigen, T-CellT-Cell ExhaustionAnti-Retroviral AgentsReceptors, Antigen, T-Cell

Identifiers

PMID42252444
PMCPMC13466494

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.